Ongoing search for diagnostic biomarkers in idiopathic normal pressure hydrocephalus

被引:22
作者
Tarnaris, Andrew [1 ]
Toma, Ahmed K. [1 ]
Kitchen, Neil D. [1 ]
Watkins, Laurence D. [1 ]
机构
[1] Natl Hosp Neurol & Neurosurg, Dept Neurosurg, London WC1N 3BG, England
关键词
Alzheimer's disease; biomarkers; CSF; diagnosis; imaging; normal pressure hydrocephalus; Parkinson's disease; vascular dementia; CEREBRAL-BLOOD-FLOW; CEREBROSPINAL-FLUID FLOW; WHITE-MATTER LESIONS; SOMATOSTATIN-LIKE IMMUNOREACTIVITY; INTRACRANIAL COMPARTMENT VOLUMES; MAGNETIC-RESONANCE-SPECTROSCOPY; POSITRON-EMISSION-TOMOGRAPHY; AQUEDUCTAL CSF FLOW; PHASE-CONTRAST MR; ALZHEIMERS-DISEASE;
D O I
10.2217/BMM.09.37
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Idiopathic normal pressure hydrocephalus is a syndrome, which typically has a clinical presentation of gait/balance disturbance, often accompanied by cognitive decline and/or urinary incontinence. Its diagnosis is based on relevant history and clinical examination, appropriate imaging findings and physiological testing. The clinical picture of idiopathic normal pressure hydrocephalus may occasionally be difficult to distinguish from that of Alzheimer's dementia, subcortical ischemic vascular dementia and Parkinson's disease. The aim of this article is to systematically review the literature from the last 29 years in order to identify cerebrospinal fluid (CSF) or imaging biomarkers that may aid in the diagnosis of the syndrome. The authors concluded that no CSF or imaging biomarker is currently fulfilling the criteria required to aid in the diagnosis of the condition. However, a few studies have revealed promising CSF and imaging markers that need to be verified by independent groups. The reasons that the progress in this field has been slow so far is also commented on, as well as steps required to apply the current evidence in the design of future studies within the field.
引用
收藏
页码:787 / 805
页数:19
相关论文
共 196 条
[11]  
Assaf Y, 2006, AM J NEURORADIOL, V27, P1717
[12]  
Aygok G, 2006, ACTA NEUROCHIR SUPPL, V96, P348
[13]  
Baba M, 1978, No To Shinkei, V30, P697
[14]   Cerebral hemodynamics before and after shunting in normal pressure hydrocephalus [J].
Bakker, SLM ;
Boon, AJW ;
Wijnhoud, AD ;
Dippel, DWJ ;
Delwel, EJ ;
Koudstaal, PJ .
ACTA NEUROLOGICA SCANDINAVICA, 2002, 106 (03) :123-127
[15]   Can MR measurement of intracranial hydrodynamics and compliance differentiate which patient with idiopathic normal pressure hydrocephalus will improve following shunt insertion? [J].
Bateman, G. A. ;
Loiselle, A. M. .
ACTA NEUROCHIRURGICA, 2007, 149 (05) :455-462
[16]   The pathophysiology of the aqueduct stroke volume in normal pressure hydrocephalus: can co-morbidity with other forms of dementia be excluded? [J].
Bateman, GA ;
Levi, CR ;
Schofield, P ;
Wang, Y ;
Lovett, EC .
NEURORADIOLOGY, 2005, 47 (10) :741-748
[17]   Pulse wave encephalopathy: a spectrum hypothesis incorporating Alzheimer's disease, vascular dementia and normal pressure hydrocephalus [J].
Bateman, GA .
MEDICAL HYPOTHESES, 2004, 62 (02) :182-187
[18]   The reversibility of reduced cortical vein compliance in normal-pressure hydrocephalus following shunt insertion [J].
Bateman, GA .
NEURORADIOLOGY, 2003, 45 (02) :65-70
[19]   Idiopathic normal pressure hydrocephalus: the benefits and problems of shunting [J].
Batra, Sachin ;
Rigamonti, Daniele .
NATURE CLINICAL PRACTICE NEUROLOGY, 2009, 5 (02) :80-81
[20]   CSF SOMATOSTATIN-LIKE IMMUNOREACTIVITY IN DEMENTIA [J].
BEAL, MF ;
GROWDON, JH ;
MAZUREK, MF ;
MARTIN, JB .
NEUROLOGY, 1986, 36 (02) :294-297